423
Views
20
CrossRef citations to date
0
Altmetric
Genomics

Clinicopathologic correlations in a family with a TBK1 mutation presenting as primary progressive aphasia and primary lateral sclerosis

ORCID Icon, , , ORCID Icon, , , , , & ORCID Icon show all
Pages 568-575 | Received 10 Apr 2019, Accepted 04 Jun 2019, Published online: 27 Jun 2019
 

Abstract

Mutations in the TANK binding kinase 1 gene (TBK1) are associated with amyotrophic lateral sclerosis and/or frontotemporal dementia; however, the range of clinical phenotypes and neuropathological changes associated with these mutations have not yet been completely elucidated. We present the detailed clinical, neuroimaging, and neuropathological features of two brothers carrying the TBK1 p.Gly272_Thr331del mutation. Both presented with very similar and unusual clinical features including primary progressive aphasia and asymmetric-onset primary lateral sclerosis (PLS). Repeated electrophysiological studies failed to reveal any lower motor neuron involvement. Neuropathological evaluation of both cases revealed frontotemporal lobar degeneration with TDP-43 proteinopathy type B and selective involvement of upper motor neurons with TDP-43 inclusions. The stereotypical clinical presentation and neuropathological findings in these cases widen the phenotypic spectrum of TBK1 mutations and provide insights into the pathogenesis of PLS.

Declaration of interest

None of the authors has conflicts of interest to declare.

Additional information

Funding

This work was supported by Canadian Institutes of Health Research (CIHR (grant 74580)), Canadian Consortium on Neurodegeneration in Aging (CCNA (grant 137794)), the ALS Canada-Brain Canada Hudson Grant (IM, RH) and National Institute of Neurological Disorders and Stroke (NIH/NINDS (grants R35 NS097261 and UG3 NS103870)) (RR). Dr. Hsiung holds the Ralph Fisher Alzheimer Society of BC professorship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.